LFVNLifeVantage Corporation

6.690USD+2.92%Mkt Cap: 84.40M $P/E: 14.87

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin an…

Key Statistics

Company
Market Cap84.40M $
Enterprise Value81.62M $
Revenue (TTM)195.32M $
Gross Profit183.67M $
Net Income (TTM)9.80M $
Revenue/Share15.63 USD
Last Price6.690 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees232
CountryUS
SectorConsumer Defensive
IndustryPackaged Foods
ISIN
Valuation
P/E (Trailing)14.87
P/E (Forward)14.56
PEG0.36
EV/EBITDA8.16
EV/Revenue0.42
P/S0.43
P/B2.52
EPS (TTM)0.46
EPS (Forward)0.46
52W Range
3.90027% of range14.28
52W High14.28 USD
52W Low3.900 USD
Profitability
Gross Margin80.37%
Oper. Margin4.07%
EBITDA Margin5.12%
Profit Margin4.29%
ROE28.30%
ROA13.63%
Growth
Revenue Growth-25.20%
Earnings Growth-58.50%
Cash Flow & Leverage
Operating CF11.88M $
CapEx (TTM)1.37M $
FCF Margin1.04%
FCF Yield2.41%
Net Debt-2.28M $
Net Debt/EBITDA-0.23
Balance Sheet
Debt/Equity0.34
Current Ratio1.96
Quick Ratio0.85
Book Value/Sh2.644 USD
Cash/Share0.9890 USD
Dividends
Fwd Div Rate0.2000 USD
Trail. Div Rate0.1800 USD
Div. Yield3.07%
5Y Avg Yield
Payout Ratio40.00%
Ex-Div DateJun 1, 2026
Pay DateJun 15, 2026
Splits
Last Split1:7
Split DateOct 19, 2015
Analyst Consensus
Rating
Target (Mean)7.000 USD
Upside (mean)+4.6%
Target Range5.000 USD9.000 USD
$5.000+4.6% to mean$9.000
# Analysts2
Ownership
Shares Out.12.62M
Float8.83M
Insiders14.48%
Institutions53.60%
Short Interest
Short Ratio10.0d
Short % Float12.66%
Short % Out.10.01%
Shares Short1.26M
Short (prev mo.)1.88M
Technical
SMA 506.561 (+2.0%)
SMA 2005.974 (+12.0%)
Beta0.76
S&P 52W Chg18.16%
Avg Vol (30d)80.10K
Avg Vol (10d)51.55K
Technical Indicators
RSI (14)54.7
MACD0.0229
MACD Signal0.0119
MACD Hist.+0.0110
BB Upper6.838 USD
BB Middle6.535 USD
BB Lower6.232 USD
BB Width9.28%
ATR (14)0.3308 USD
Vol Ratio (20d)0.68x